Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents
Public ClinicalTrials.gov record NCT02140762. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Randomized, Controlled, Observer-Blind, Multi-Center Study Assessing the Effectiveness, Immunogenicity and Safety of Novartis Meningococcal ABCWY Vaccine Administered to Healthy Adolescents in the U.S.
Study identification
- NCT ID
- NCT02140762
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Novartis Vaccines
- Industry
- Enrollment
- 305 participants
Conditions and interventions
Conditions
Interventions
- MenABCWY Biological
- Placebo Other
- MenACWY Biological
Biological · Other
Eligibility (public fields only)
- Age range
- 10 Years to 18 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2014
- Primary completion
- Oct 31, 2014
- Completion
- Jan 31, 2015
- Last update posted
- Sep 11, 2018
2014 – 2015
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Accelovance, Inc | Huntsville | Alabama | 35802 | — |
| The Children's Clinic of Jonesboro, P.A. | Jonesboro | Arkansas | 72401 | — |
| Accelovance, Inc | Melbourne | Florida | 32935 | — |
| Heartland Research Associates LLC | Newton | Kansas | 67114 | — |
| Heartland Research Associates, LLC | Wichita | Kansas | 67207 | — |
| Bluegrass Clinical Research, Inc. | Louisville | Kentucky | 40291 | — |
| Meridian Clinical Research | Omaha | Nebraska | 68134 | — |
| Senders Pediatrics | Cleveland | Ohio | 44121 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02140762, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 11, 2018 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02140762 live on ClinicalTrials.gov.